Cipla Limited
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- India
- Registered address
- Virgonagar, Old Madras Road, Bengaluru, Karnataka 560049, India (IND)
- Operations here
- analysisapi manufacture
- FDA identifiers
- FEI 3002806691 · DUNS 915154892
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2024-11-13
- VAIDrug Quality Assurance2020-01-31
- VAIDrug Quality Assurance2019-07-19
- VAIDrug Quality Assurance2017-04-05
- VAIDrug Quality Assurance2014-07-25
- VAIDrug Quality Assurance2012-06-28
- VAIDrug Quality Assurance2009-04-09
Drugs this plant is listed as making
7 distinct drugs across 23 products name this site in their FDA label.
- Amlodipine BesylateCipla USA Inc.
- Esomeprazole magnesiumCipla USA Inc.
- lenalidomideCipla USA Inc.
- NintedanibExelan Pharmaceuticals Inc.
- pantoprazole sodium granulesCipla USA Inc.
- TopiramateCipla USA Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.